ANIK

Anika Therapeutics Inc

14.55

Nov 06 • 3:59 PM ET -4.78 (-24.73%)

14.55

Aftermarket • 7:30 PM ET 0.00 (0.00%)

Healthcare Drug Manufacturers - Specialty & Generic USA Micro NASD

Nov 06, 10:53 AMAnika raises 2026 revenue and EBITDA margin guidance after strong Q3 despite HYALOFAST setback and U.S. OA pricing pressure

Peers: BVS LFCR PCRX VCEL ORGO EOLS MDXG CNMD ZBH SNN

| Held by: VTI IWM DFSV VXF IWN DFAS FSMD SCHA VTWO DFMC

Scroll to Statements

Index	RUT
Market Cap	194.72M
Enterprise Value	175.91M
Income	-1.77M
Sales	123.43M
Book/sh	10.27
Cash/sh	3.36
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	235
IPO	May 03, 1993

P/E	-
Forward P/E	15.32
PEG	0.13
P/S	1.58
P/B	1.42
P/C	4.33
P/FCF	85.03
EV/EBITDA	57.30
EV/Sales	1.43
Quick Ratio	2.72
Current Ratio	3.86
Debt/Eq	0.19
LT Debt/Eq	0.18
Option/Short	Yes / Yes

EPS (ttm)	-0.14
EPS next Y	0.95
EPS next Q	0.19
EPS this Y	854.55%
EPS next Y	-9.52%
EPS next 5Y	118.66%
EPS past 3/5Y	9.40% 14.76%
Sales past 3/5Y	-10.28% -2.86%
EPS Y/Y TTM	93.57%
Sales Y/Y TTM	9.42%
EPS Q/Q	85.63%
Sales Q/Q	9.98%
Earnings	Nov 06 BMO
EPS/Sales Surpr.	-30.95% 3.94%

Insider Own	6.28%
Insider Trans	0.24%
Inst Own	91.48%
Inst Trans	-0.85%
ROA	-0.14%
ROE	-0.18%
ROIC	-1.09%
Gross Margin	63.40%
Oper. Margin	-2.11%
Profit Margin	-1.43%
SMA20	-28.28%
SMA50	-28.62%
SMA200	-10.76%
Trades

Shs Outstand	13.39M
Shs Float	12.54M
Short Float	2.92%
Short Ratio	3.49
Short Interest	0.37M
52W High	22.88 -36.41%
52W Low	9.01 61.49%
Volatility	12.52% 5.70%
ATR (14)	1.30
RSI (14)	23.76
Beta	0.23
Rel Volume	2.81
Avg Volume	104.76K
Volume	294,148

Perf Week	-30.55%
Perf Month	-24.34%
Perf Quarter	-29.64%
Perf Half Y	-1.49%
Perf YTD	51.40%
Perf Year	49.23%
Perf 3Y	-31.37%
Perf 5Y	-67.69%
Perf 10Y	-65.14%
Recom	1.00
Target Price	23.00
Prev Close	19.33
Price	14.55
Change %	-24.73%

Consensus

Strong Buy

Avg. Price Target

$23.00

Implied Upside

+58.1%

Analysts7incl. previous ratings

Rating Distribution4 Buy · 2 Hold · 1 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Sep 18, 2026	Resumed	RB. Riley Securities	Buy	$23	+58.1%
Apr 17, 2025	Initiated	RB. Riley Securities	Buy	$21	+44.3%
Nov 01, 2024	Reiterated	BBarrington Research	Outperform	$37 → $25	+71.8%
Aug 14, 2023	Upgrade	BBarrington Research	Mkt Perform → Outperform	$24	+64.9%
Mar 07, 2023	Downgrade	BBarrington Research	Outperform → Mkt Perform
Nov 09, 2022	Upgrade	BBarrington Research	Mkt Perform → Outperform	$31	+113.1%
Oct 14, 2022	Resumed	SStephens	Equal-Weight	$26	+78.7%
Mar 09, 2022	Downgrade	SStephens	Overweight → Equal-Weight	$35	+140.5%
Mar 09, 2022	Downgrade	BBarrington Research	Outperform → Mkt Perform
Nov 16, 2021	Initiated	SStephens	Overweight	$55	+278.0%
Jul 16, 2021	Initiated	UUBS	Neutral	$46	+216.2%
Dec 16, 2020	Upgrade	BBarrington Research	Mkt Perform → Outperform	$43	+195.5%
May 08, 2020	Downgrade	BBarrington Research	Outperform → Mkt Perform
Jan 21, 2020	Upgrade	SSidoti	Neutral → Buy	$61	+319.2%
Jan 10, 2020	Upgrade	FFirst Analysis Sec	Outperform → Strong Buy	$65	+346.7%
Nov 05, 2019	Initiated	BBWS Financial	Sell	$29	+99.3%
Sep 24, 2019	Reiterated	BBarrington Research	Outperform	$49 → $58	+298.6%
Sep 23, 2019	Downgrade	FFirst Analysis Sec	Strong Buy → Outperform	$54	+271.1%
Jul 25, 2019	Upgrade	FFirst Analysis Sec	Neutral → Strong Buy	$37 → $54	+271.1%
Feb 22, 2019	Downgrade	SSidoti	Buy → Neutral	$56 → $41	+181.8%

Nov-06-26 10:47AM	Anika Therapeutics Misses On EPS But Raises 2026 Floor As Gross Margin Slips And Hyalofast Hits An FDA Wall (Earnings Whispers) -24.73%
07:22AM	Anika: Q3 Earnings Snapshot (Associated Press)
07:05AM	Anika Reports Third Quarter 2026 Financial Results (GlobeNewswire)
Oct-29-26 01:00PM	Anika's Margin Breakout Faces Its First Test As OEM Pull-Forward Unwinds (Earnings Whispers)
Oct-22-26 04:01PM	Anika to Issue Third Quarter 2026 Financial Results on Friday, November 6, 2026 (GlobeNewswire)
01:53PM	Loading…
Jul-30-26 01:53PM	These 2 Biotech Stocks Hit New 52-Week Highs Today And CORT Clocked Its Best Day In Nearly 16 Months (Stocktwits) +11.75%
Jul-29-26 05:02PM	Anika Therapeutics Inc (ANIK) Q2 2026 Earnings Call Highlights: Record Revenue and Margin ... (GuruFocus.com) +6.73%
07:20AM	Anika: Q2 Earnings Snapshot (Associated Press)
07:05AM	Anika Reports Second Quarter 2026 Financial Results (GlobeNewswire)
Jul-15-26 04:01PM	Anika to Issue Second Quarter 2026 Financial Results on Wednesday, July 29, 2026 (GlobeNewswire)
Jun-05-26 05:00PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Apr-29-26 07:14AM	Anika: Q1 Earnings Snapshot (Associated Press) -18.81%
07:05AM	Anika Reports First Quarter 2026 Financial Results (GlobeNewswire)
Apr-15-26 04:01PM	Anika to Issue First Quarter 2026 Financial Results on Wednesday, April 29, 2026 (GlobeNewswire)
Apr-07-26 03:35PM	Revance CEO Nadeem Moiz on Expansion, Opportunities & Capitalization (Exec Edge)
05:00PM	Loading…
Apr-03-26 05:00PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Mar-03-26 03:29AM	Anika Therapeutics Touts $3B TAM, Cingal & Hyalofast Growth Plans at Canaccord MSK Conference (MarketBeat)
Feb-26-26 04:09PM	Anika Therapeutics Inc (ANIK) Q4 2025 Earnings Call Highlights: Strong International Growth and ... (GuruFocus.com) +16.91% +12.28%
12:15PM	Anika Therapeutics (ANIK) Q4 Earnings and Revenues Beat Estimates (Zacks)
10:59AM	Anika Therapeutics Q4 Earnings Call Highlights (MarketBeat)
07:35AM	Anika: Q4 Earnings Snapshot (Associated Press Finance)
07:05AM	Anika Reports Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
Feb-18-26 04:01PM	Anika To Present at the Canaccord Genuity 2026 Musculoskeletal Conference (GlobeNewswire)
Feb-12-26 04:01PM	Anika to Issue Fourth Quarter and Year-End 2025 Financial Results on Thursday, February 26, 2026 (GlobeNewswire)
Jan-08-26 07:00AM	Anika Therapeutics Announces Leadership Transition (GlobeNewswire)
Nov-06-25 06:00PM	Anika Therapeutics Inc (ANIK) Q3 2025 Earnings Call Highlights: Strong Growth in Regenerative ... (GuruFocus.com)
Nov-05-25 08:25AM	Anika Therapeutics (ANIK) Q3 Earnings and Revenues Top Estimates (Zacks)
07:22AM	Anika: Q3 Earnings Snapshot (Associated Press Finance)
07:05AM	Anika Reports Third Quarter 2025 Financial Results (GlobeNewswire)
07:00AM	Anika Therapeutics Reports Filing of Final PMA Module for Hyalofast Cartilage Repair Scaffold and Data from U.S. Pivotal FastTRACK Phase III Study (GlobeNewswire)
08:43AM	Loading…
Nov-04-25 08:43AM	Anika Therapeutics Inc (ANIK) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Oct-23-25 04:01PM	Anika to Issue Third Quarter 2025 Financial Results on Wednesday, November 5, 2025 (GlobeNewswire)
Sep-19-25 06:50AM	Arcturus Therapeutics (ARCT) Surges 8.7%: Is This an Indication of Further Gains? (Zacks)
Sep-05-25 05:00AM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Aug-29-25 09:55AM	Wall Street Analysts See a 98.59% Upside in Anika (ANIK): Can the Stock Really Move This High? (Zacks)
Aug-20-25 12:00PM	Anika (ANIK) Upgraded to Buy: Here's What You Should Know (Zacks)
Jul-30-25 08:15AM	Anika Therapeutics (ANIK) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -27.42%
07:21AM	Anika: Q2 Earnings Snapshot (Associated Press Finance)
07:05AM	Anika Reports Second Quarter 2025 Financial Results (GlobeNewswire)
07:00AM	Anika Reports Topline Results from U.S. Pivotal FastTRACK Phase III Study for Hyalofast Cartilage Repair Scaffold and Provides Program Update (GlobeNewswire)
Jul-29-25 10:04AM	Anika Therapeutics Inc (ANIK) Q2 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
08:15AM	uniQure (QURE) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
Jul-21-25 10:11AM	Recursion Pharmaceuticals (RXRX) Soars 5.8%: Is Further Upside Left in the Stock? (Zacks)
Jul-16-25 04:01PM	Anika to Issue Second Quarter 2025 Financial Results on Wednesday, July 30, 2025 (GlobeNewswire)
Jul-03-25 05:00PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jun-05-25 05:00PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
May-20-25 08:00AM	Sidoti Events, LLC's Virtual May Micro-Cap Conference (ACCESSWIRE)
May-12-25 05:00PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
09:29AM	Company News for May 12, 2025 (Zacks)
May-10-25 03:04AM	Anika Therapeutics Inc (ANIK) Q1 2025 Earnings Call Highlights: Strategic Growth Amidst Revenue ... (GuruFocus.com)
May-09-25 08:35AM	Anika Therapeutics (ANIK) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -21.03%
07:44AM	Anika Therapeutics Posts Wider Loss From Cont. Ops. In Q1 (RTT News)
07:28AM	Anika: Q1 Earnings Snapshot (Associated Press Finance)
07:05AM	Anika Reports First Quarter 2025 Financial Results (GlobeNewswire)
May-08-25 09:45AM	Earnings To Watch: Anika Therapeutics Inc (ANIK) Reports Q1 2025 Result (GuruFocus.com)
09:05AM	Vericel Corporation (VCEL) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
May-07-25 04:01PM	Anika to Participate in the Sidoti Virtual Investor Conference (GlobeNewswire)
May-05-25 09:28AM	Is the Options Market Predicting a Spike in Anika Therapeutics Stock? (Zacks)
Apr-25-25 09:00AM	Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, 2025 (GlobeNewswire)
Apr-07-25 05:00PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -5.60%
Apr-03-25 08:44AM	Are Options Traders Betting on a Big Move in Anika Therapeutics (ANIK) Stock? (Zacks)
Mar-13-25 06:43AM	Q4 2024 Anika Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents) -11.10%
03:09AM	Anika Therapeutics Inc (ANIK) Q4 2024 Earnings Call Highlights: Navigating Growth and Challenges (GuruFocus.com)
Mar-12-25 05:25PM	Anika Therapeutics (ANIK) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:33PM	Anika: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Anika Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Mar-07-25 06:00AM	Anika Completes Divestiture of Parcus Medical (GlobeNewswire)
Mar-01-25 06:42AM	Is Anika Therapeutics, Inc. (ANIK) the Best Small Cap Pharma Stocks to Buy Now? (Insider Monkey)
Feb-26-25 08:00AM	Anika to Issue Fourth Quarter and Year-End 2024 Financial Results on Wednesday, March 12, 2025 (GlobeNewswire)
Feb-25-25 08:00AM	Anika To Present at the Canaccord Genuity 2025 Musculoskeletal Conference (GlobeNewswire)
Dec-23-24 04:01PM	Anika To Participate in 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-03-24 08:30AM	Sidoti Events, LLC's Virtual December Small-Cap Conference (ACCESS Newswire)
Nov-22-24 04:16PM	Anika To Participate in December 2024 Investor Conferences (GlobeNewswire)
Nov-01-24 03:07AM	Anika Therapeutics Inc (ANIK) Q3 2024 Earnings Call Highlights: Strategic Shifts Amid Revenue ... (GuruFocus.com)
Oct-31-24 11:00AM	Arthrosurface Returns to it Roots Following Divestiture from Anika Therapeutics (PR Newswire) -30.67%
08:25AM	Anika Therapeutics (ANIK) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
07:18AM	Anika: Q3 Earnings Snapshot (Associated Press Finance)
07:05AM	Anika Reports Third Quarter 2024 Financial Results (GlobeNewswire)
07:00AM	Anika Announces Strategic Update of Business with Sale of Arthrosurface and Plan to Divest Parcus Medical (GlobeNewswire)
Oct-30-24 09:19AM	Anika Therapeutics Inc (ANIK) Q3 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Oct-17-24 04:01PM	Anika Announces Third Quarter 2024 Results Conference Call Date (GlobeNewswire)
Oct-09-24 06:04PM	Anika Therapeutics Inc (ANIK) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges ... (GuruFocus.com)
Oct-04-24 04:01PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Sep-09-24 04:45PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Aug-15-24 04:01PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Aug-09-24 07:41AM	Anika Therapeutics, Inc. (ANIK): Are Hedge Funds Bullish on This Caligan Partners-Approved Stock? (Insider Monkey)
Aug-08-24 06:35PM	Anika Therapeutics (ANIK) Q2 Earnings Lag Estimates (Zacks)
05:27PM	Anika: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Anika Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Aug-05-24 04:01PM	Anika to Participate in the Sidoti Virtual Investor Conference (GlobeNewswire)
Jul-25-24 09:00AM	Anika to Issue Second Quarter 2024 Financial Results on Thursday, August 8, 2024 (GlobeNewswire)
Jul-16-24 07:19AM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jul-11-24 08:30AM	Anika Announces Full Market Release of the Integrity Implant System, a Regenerative Hyaluronic Acid-Based Scaffold for Rotator Cuff and Other Tendon Repairs (GlobeNewswire)
Jul-01-24 10:35AM	Orthopedic Regenerative Surgical Products Market Size to Reach USD 6.6 Billion By 2033, at 4.4 CAGR: Insights by Dimension Market Research (GlobeNewswire)
Jun-07-24 04:01PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
May-28-24 04:05PM	Anika Enters into Cooperation Agreement with Caligan Partners (GlobeNewswire)
May-09-24 12:22PM	Anika Therapeutics, Inc. (NASDAQ:ANIK) Q1 2024 Earnings Call Transcript (Insider Monkey) -11.28%
10:59AM	Q1 2024 Anika Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
04:07AM	Anika Therapeutics Inc (ANIK) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and ... (GuruFocus.com)
May-08-24 08:57PM	ANIK Stock Earnings: Anika Therapeutics Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Jellison William R	Former Director	Aug 07 '26	Proposed Sale	21.07	16,864	355,255		Aug 07 05:28 PM
Fischetti Gary P	Director	Aug 03 '26	Buy	20.75	1,000	20,745	53,015	Aug 05 04:30 PM
Fischetti Gary P	Director	Aug 04 '26	Buy	20.32	1,000	20,315	54,015	Aug 05 04:30 PM
HENNEMAN JOHN B III	Director	May 01 '26	Buy	14.66	5,000	73,320	54,871	May 04 08:34 AM
Griffin Stephen D.	President and CEO	Apr 30 '26	Buy	12.29	12,200	149,881	36,163	Apr 30 05:22 PM

Anika Therapeutics, Inc. engages in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company's main focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management, Regenerative Solutions, Sports Medicine and Arthrosurface Joint Solutions, and its products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika Therapeutics was founded in 1992 and is headquartered in Bedford, MA.

Executive ChairDr. Cheryl Renee Blanchard Ph.D.

PresidentMr. Stephen D. Griffin

Senior VPMr. Ian W. McLeod

Executive Director of Corporate Development & Investor RelationsMr. Matthew Hall

VP & Chief Human Resources OfficerMs. Lisa Funiciello

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ANIK

Anika Therapeutics Inc

Upgrade your Finviz experience